Alert: Rating Downgrade (12/1/23)-Tenet Healthcare Corp (NYSE: THC).


Stock Rating Downgrade

In the last week the Value Trend Rating for Tenet Healthcare Corp (NYSE: THC) weakened from B to C reflecting eroding fundamentals and low Appreciation Potential.


Recent Price Action

Tenet Healthcare Corp (NYSE: THC) stock closed at $71.01 on 12/1/23 after a large increase of 2.9%. Moreover, above average trading volume at 133% of normal accompanied the advance. The stock has risen 4.8% during the last week and has performed in line with the market over the last nine months.

Current PriceTarget Research Rating

With future capital returns forecasted to be above the cost of capital, THC is expected to continue to be a major Value Builder.

Tenet Healthcare has a current Value Trend Rating of C (High Neutral). The Value Trend Rating reflects highly consistent signals from PTR’s two proprietary measures of a stock’s attractiveness. Tenet Healthcare has a neutral Appreciation Score of 59 and a neutral Power Rating of 59, with the High Neutral Value Trend Rating the result.

Be the first to comment

Leave a Reply

Your email address will not be published.